Elsevier and Journals of the American College of Cardiology (JACC) partner to launch the Heart Disease Healthcare Hub

Elsevier, a global leader in information and data analytics , is pleased to announce the launch of the Heart Disease Healthcare Hub in partnership with the JACC Journals – Journals of the American College of Cardiology. The Heart Disease Healthcare Hub is a one-stop shop for clinical and educational cardiology content for healthcare professionals, with new, evidence-based content added throughout the year.

According to the World Health Organization, cardiovascular diseases (CVD) are the leading cause of death globally. In the United States, the Centers for Disease Control and Prevention lists heart disease as the leading cause of death, with about 1 in every 5 deaths from cardiovascular disease. Given the alarming cardiovascular disease statistics, the Heart Disease Healthcare Hub equips clinicians with vital resources for clinical review and patient education, aiming for improved patient outcomes by identifying those at the highest risk of CVD.

From the latest evidence-based clinical resources and information about prevention and treatment options available to patients, clinicians and healthcare providers can browse freely available evidence-based content from ClinicalKey, including:

• Clinical overviews

• Drug monographs

• Care Plans

• Nursing Skills

• Patient Education

Users can also access content from JACC Journals of the American College of Cardiology, including podcasts, journal articles, and case reports to support patients managing heart disease.

Notes for editors

About JACC Journals – American College of Cardiology

The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or follow @ACCinTouch.

The ACC’s family of JACC Journals rank among the top cardiovascular journals in the world for scientific impact. The flagship journal, the Journal of the American College of Cardiology (JACC) — and family of specialty journals consisting of JACC: Advances, JACC: Asia, JACC: Basic to Translational Science, JACC: CardioOncology, JACC: Cardiovascular Imaging, JACC: Cardiovascular Interventions, JACC: Case Reports, JACC: Clinical Electrophysiology and JACC: Heart Failure — pride themselves on publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org 新しいタブ／ウィンドウで開く.

About Elsevier Health

Elsevier Health represents our unique position to leverage knowledge, data, and technology to help clinicians, leaders, educators and students globally. Through our research, we have identified Five Pillars to Shape the Future of Health, which will guide our actions for the future. These pillars focus on the need to improve access to evidence-based information to tackle the infodemic; prepare more future health professionals with effective tools and resources; provide insights that improve patient outcomes; deliver healthcare that is truly inclusive; and support a more personalized and localized healthcare experience. Elsevier Health supports healthcare professionals throughout their career journey from education through clinical practice, by providing current, accessible, evidence–based information, that can help empower clinicians to provide the best healthcare possible.

エルゼビアについて

エルゼビアは情報分析を専門としたグローバル企業として、研究者や医療専門家の方々を支援し、社会にとっての利益最大化に向けて、科学や医療の進展を支えています。これは、信頼できるエビデンスによるコンテンツと高度なAI対応によるデジタル技術に基づく革新的なソリューションにより、知見の集積や重要な意思決定を支援することで実現されています。

エルゼビアは、全世界で9,700人の従業員（うち技術者2,300人以上）を抱え、140年以上にわたって、研究者、図書館員、アカデミックリーダー、資金提供者、政府、研究開発集約型企業、医師、看護師、将来の医療専門家、教育者など研究・医療分野におけるパートナーの重要な活動を支援してきました。エルゼビアが刊行する3,000誌以上の科学ジャーナルと代表的な参考書には、The Lancet 新しいタブ／ウィンドウで開く、Cell Press 新しいタブ／ウィンドウで開くおよびGray’s Anatomyなどをはじめとする、各分野を代表する主要なタイトルが含まれています。 エルゼビア・ファンデーション 新しいタブ／ウィンドウで開くとの活動を通し、私たちがサービスを提供する地域社会と連携して、開発途上国を含む世界中の医学、研究、医療分野における、インクルージョン＆ダイバーシティ（I&D）の改善に努めています。

エルゼビアは、専門家および企業向けの情報分析および意思決定ツールのグローバルプロバイダーであるRELX Group 新しいタブ／ウィンドウで開くの一事業を担っています。エルゼビアの事業内容、デジタルソリューション、コンテンツなどの詳細については、www.elsevier.comをご覧ください。